Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Stem cells from fat improve dog wound healing better than standard treatment.

Conditioned media from human amniotic fluid-derived stem cells helps skin heal and protects against aging from sun exposure.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Mesenchymal stem-cell derived extracellular vesicles show promise in plastic surgery but need more research for safe use.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Stem cells from diabetic mice can still help heal wounds effectively.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

Immune system issues may contribute to female pattern hair loss.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Mesenchymal stem cells and their secretions might help treat chronic skin inflammation in atopic dermatitis.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Potential therapeutic targets for scarring hair loss are identified.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.